Wolverine Trading
NYMX

Wolverine Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Wolverine Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,600
Closed -$55K – 5350
2020
Q2 		$55K Buy
15,600
+4,200
+37% +$13.3K ﹤0.01% 4295
2020
Q1 		$25K Buy
+11,400
New +$32K ﹤0.01% 4401
2019
Q1 		– Sell
-28,600
Closed -$41K – 5543
2018
Q4 		$41K Sell
28,600
-37,600
-57% -$68.8K ﹤0.01% 4201
2018
Q3 		$163K Sell
66,200
-34,400
-34% -$102K ﹤0.01% 4356
2018
Q2 		$426K Hold
100,600
– – ﹤0.01% 3282
2018
Q1 		$426K Buy
100,600
+42,100
+72% +$146K ﹤0.01% 3282
2017
Q4 		$193K Sell
58,500
-7,500
-11% -$27.4K ﹤0.01% 4187
2017
Q3 		$252K Sell
66,000
-11,800
-15% -$44.7K ﹤0.01% 3513
2017
Q2 		$358K Buy
77,800
+6,400
+9% +$26.3K ﹤0.01% 2784
2017
Q1 		$263K Buy
+71,400
New +$235K ﹤0.01% 3184

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Trading's NYMX Position: Q4 2020 in Review

Wolverine Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2020, closing a stake of 10,534 shares — an estimated $27K sold.

Wolverine Trading first reported a position in NYMX in Q2 2017 and held it in 11 quarters. The position peaked at $272K in Q3 2017. 58 funds tracked by Wall St. Rank hold NYMX as of Q4 2020.

  • Wolverine Trading reported no remaining Nymox Pharmaceutical Corp position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 10,534 Nymox Pharmaceutical Corp shares in Q4 2020, an estimated $27K.
  • Wolverine Trading first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 11 quarters.
  • Wolverine Trading's Nymox Pharmaceutical Corp position peaked at $272K in Q3 2017.
  • 58 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.